Shimadzu Scientific Instruments (SSI) is the North American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. SSI was established in 1975 to provide analytical solutions to a wide range of laboratories in the Americas. With a vast installed base and preferred vendor status at many institutions, SSI's instruments are used by top researchers across the globe, customers who can count on the stability, experience, and support only Shimadzu offers.
Shimadzu's product line flexibility enables chromatographers in any environment to select the instrument best suited to their application. Shimadzu instruments are found in a wide range of labs, including academic research, pharmaceutical, forensic, food and beverages, petrochemical, life sciences, and environmental.
Shimadzu provides free technical support for the life of the instruments and encourages customer alliances to further product development.
Shimadzu offers a wide range of advanced UHPLC/HPLC, GC, and mass spectrometry systems and components. Key systems include:
Shimadzu's US headquarters includes a customer service and training center, a solution center to showcase technologies, and a new innovation center that will house a team of engineers and scientists whose goal will be to develop close collaborations with universities, government agencies, and industry centers. Shimadzu¹s regional facilities, strategically located around the US, provide customers with local sales, service, and technical support.
7120 Riverwood Drive Columbia,MD 21046
TELEPHONE
(800)477-1227
(410)381-1227
FAX
(410)381-1222
webmaster@shimadzu.com
WEB SITE
www.ssi.shimadzu.com
NUMBER IF EMPLOYEES
US:420
Worldwide:11,050
YEAR FOUNDED
Shimadzu Scientific
Instruments:1975
Shimadzu Corporation:1875
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.